COVID-19 isn't just a respiratory illness — it can silently attack the heart. New research reveals that the virus accelerates ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

People with certain conditions, such as diabetes, renal failure, chronic lung disease, and immunocompromised persons, as well as the elderly, are considered to be at high risk of severe disease from ...

COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...

A new study, which has found that Covid-19, caused by the Sars-CoV-2 virus is linked to accelerated plaque buildup in the ...

Learn about our Editorial Policies. At the height of the SARS-CoV-2 pandemic, researchers in Thomas Marichal’s immunophysiology laboratory at the University of Liège were studying samples collected ...

The AI drug discoverer’s oral small molecule was able to reduce SARS-CoV levels in the lungs of infected mice and also neutralized other RNA viruses like hepatitis C, norovirus and flu in ...

Study senior author Professor Junbo Ge, of Fudan University in Shanghai, China, said: “COVID-19, caused by SARS-CoV-2, is ...

This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...

SARS-CoV-2 is the virus that spreads COVID-19 ... reversed the increased ACE2 expression on lung, intestinal, and immune cells, thus reducing susceptibility to viral invasion." ...